First Time Loading...

Zymeworks Inc
NYSE:ZYME

Watchlist Manager
Zymeworks Inc Logo
Zymeworks Inc
NYSE:ZYME
Watchlist
Price: 8.26 USD 1.85% Market Closed
Updated: Apr 29, 2024

Zymeworks Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Zymeworks Inc
Cash from Financing Activities Peer Comparison

Comparables:
RPTX
FUSN
AUPH
EDT
SBFM

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Zymeworks Inc
NYSE:ZYME
Cash from Financing Activities
$81.8m
CAGR 3-Years
-36%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Repare Therapeutics Inc
NASDAQ:RPTX
Cash from Financing Activities
$842k
CAGR 3-Years
-85%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
Cash from Financing Activities
$142m
CAGR 3-Years
-19%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash from Financing Activities
-$5.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Cash from Financing Activities
CA$5.4m
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
-1%
Sunshine Biopharma Inc
OTC:SBFM
Cash from Financing Activities
$3.4m
CAGR 3-Years
29%
CAGR 5-Years
45%
CAGR 10-Years
22%

See Also

What is Zymeworks Inc's Cash from Financing Activities?
Cash from Financing Activities
81.8m USD

Based on the financial report for Dec 31, 2023, Zymeworks Inc's Cash from Financing Activities amounts to 81.8m USD.

What is Zymeworks Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-2%

Over the last year, the Cash from Financing Activities growth was -25%. The average annual Cash from Financing Activities growth rates for Zymeworks Inc have been -36% over the past three years , -2% over the past five years .